Author

Kyle Shifflett

National Institute of Allergy and Infectious DiseasesORCID 0000-0003-0349-3579Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Amanda J. Griffin· 1 shared Andrea MarziiD· 1 shared Anthony B. EasoniD· 1 shared Blossom DamaniaiD· 1 shared Dirk P. DittmeriD· 1 shared Elizabeth R. Wrobel· 1 shared Friederike FeldmanniD· 1 shared Heinz FeldmanniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Amanda J. Griffin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 14, 2026

Kaposi Sarcoma herpesvirus reactivation and replication are dispensable for cell-lineage specific tumorigenesis in whole genome transgenic mice

Kyle Shifflett, Anthony B. Eason, Huanjuan Su…·Dirk P. Dittmer

This study shows that KSHV tumorigenesis can occur without viral reactivation or replication in a whole-genome transgenic mouse model.

DOI 10.64898/2026.06.10.731437

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintFeb 15, 2026

Low-dose VSV-EBOV vaccination provides rapid protection from lethal Ebola virus challenge

Andrea Marzi, Wakako Furuyama, Amanda J. Griffin…·Heinz Feldmann

This study evaluates the protective efficacy of low-dose VSV-EBOV vaccines in nonhuman primates, finding reduced protection with a Makona GP vaccine compared to a Kikwit GP vaccine.

DOI 10.64898/2026.02.14.705917

non-human primateexperimental assay

𝕏 PostBluesky